Network Analysis of Adult MDD and ADHD

ADHD Clinical Trial

Official title:

Network Analysis of Co-morbid Symptoms of Adult Major Depressive Disorder and Attention-deficit Hyperactivity Disorder in an Outpatient Population

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04504474
• Other study ID #: 18-056
• Status: Recruiting
• Start date: June 21, 2018
• Est. completion date: September 8, 2021

Study information

• Verified date: August 2020
• Source: Health Sciences North Research Institute
• Contact: Kuppuswami Shivakumar, M.D.
• Phone: 705-523-7100
• Email: kshivakumar[@]hsnsudbury.ca
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The study is an investigation to determine co-morbid symptoms between adult major depressive disorder (MDD) and adult attention-deficit hyperactivity disorder (ADHD) using a novel statistical technique called network analysis.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 500
• Est. completion date: September 8, 2021
• Est. primary completion date: August 8, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 60 Years

Eligibility

Inclusion Criteria:

• participants have a diagnosis of MDD or ADHD or both

• participants are competent to consent to the study

Related Conditions & MeSH terms

• ADHD

Locations

Country	Name	City	State
Canada	Kirkwood Site - Health Sciences North	Sudbury	Ontario

Sponsors (1)

Lead Sponsor	Collaborator
Health Sciences North Research Institute

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Co-morbidity	Characterize the ADHD/MDD symptom network in a psychiatric outpatient setting comprised of adults	September 8, 2021
Primary	Network reliability	Determine the stability and reliability of this network	September 8, 2021
Primary	Central symptoms	Determine the central symptoms that lead to co-activation of ADHD/MDD clusters	September 8, 2021